CHARLES T. STONE, B.A., M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
When William Gull, in 1873, first described the disease which Ord, in 1877, designated Myxedema, a clinical picture so comprehensive as to scope and accurate in detail was given to the profession that little was left for subsequent generations to add. Murray's successful treatment of a patient with the disease by the subcutaneous injection of a glycerine extract of thyroid gland, in 1891, so completed the knowledge upon the subject that nothing of value was added, excepting the oral administration of thyroid substance, until in 1893 it was shown by Magnus-Levy that there is great and constant lowering of the
STONE CT. The Occurrence of Anemia in Myxedema*†. Ann Intern Med. 1928;2:215–221. doi: https://doi.org/10.7326/0003-4819-2-2-215
Download citation file:
Published: Ann Intern Med. 1928;2(2):215-221.
Endocrine and Metabolism, Hematology/Oncology, Red Cell Disorders, Thyroid Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use